Abstracts tagged "fungal infections"

Abstract Number: 2111 • 2019 ACR/ARP Annual Meeting
Symptomatic Coccidioidomycosis Infections in Patients on Biologic Therapies
Alexander Peck¹, Ella Starobinska ², Gilbert Ortega ¹, Travis Maestas ¹, Jaclyn Leong ¹, Phan Saligrama ¹, Jawad Bilal ¹ and Dominick Sudano ³, ¹University of Arizona College of Medicine, Tucson, AZ, ²University of Arizona College of Medicine, Tucson, AL, ³Banner University Medical Center Tucson, Tucson
Background/Purpose: Studies have shown an increased risk of coccidioidomycosis infection in immunosuppressed patients. However, relationship of coccidioidomycosis infections with different immunosuppressive medication is not well…
Abstract Number: 2110 • 2019 ACR/ARP Annual Meeting
Invasive Aspergillosis in Rheumatologic Patients in Tertiary Care Hospital in Mexico
Guillermo Guaracha-Basañez¹, Carla M. Román-Montes ², María F. González-Lara ² and Alfredo Ponce-de-León ², ¹Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ²Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico city, Mexico
Background/Purpose: Fungal infections are an important cause of morbidity and mortality in patients with rheumatic diseases. Invasive aspergillosis (IA) is a fungal infection potentially fatal,…
Abstract Number: 1230 • 2018 ACR/ARHP Annual Meeting
Invasive Fungal Infection with Cryptococcal Meningitis in Patients with Systemic Lupus Erythematosus
Rodrigo Aguila Maldonado¹, Lucila Garcia², Adrian Salas³, Josefina Marcos⁴, Mariana Pera⁵, Pierina Sansinanea², Valeria Arturi⁵, Claudia Elizabeth Pena¹, Amadeo Esposto⁶, Fernanda Ferrer⁶, Virginia Angeletti⁶ and Mercedes Garcia¹, ¹Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, ²Rheumatology, HIGA General San Martin La Plata, la plata, Argentina, ³Rheumatology, HIGA General San Martin, La Plata, Argentina, ⁴HIGA San Martín, La Plata, Argentina, ⁵HIGA General San Martin La Plata, la plata, Argentina, ⁶HIGA General San Martín, La Plata, Argentina
Background/Purpose: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder with immunodeficiency associated with the disease itself and immunosuppressive treatment. Infections are very frequent events…
Abstract Number: 2410 • 2017 ACR/ARHP Annual Meeting
Serious Infection Risk in Patients with Rheumatoid Arthritis Compared to Patients with Non-Inflammatory Rheumatic Diseases: A US National Cohort Study
Bella Y. Mehta¹, Sofia Pedro², Gulsen Ozen³ and Kaleb Michaud⁴, ¹Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ²National Data Bank for Rheumatic Diseases, Wichita, KS, ³Rheumatology, Marmara University, School of Medicine, Rheumatology, Istanbul, Turkey, ⁴University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Serious infections (SI) in patients with rheumatoid arthritis (RA) are a perpetual concern. We compared the risk by first and recurrent SIs in patients…
Abstract Number: 2205 • 2014 ACR/ARHP Annual Meeting
Management of Asymptomatic Coccidioidomycosis in Patients with Rheumatic Disease
Dominick Sudano¹, Varun Bhalla², Neil M. Ampel^3,4 and Jeffrey R. Lisse⁵, ¹Rheumatology, University of Arizona, Tucson, AZ, ²University of Arizona, Tucson, AZ, ³Infectious Disease, University of Arizona, Tucson, AZ, ⁴Infectious Disease, Southern Arizona Veteran's Affairs Medical Center, Tucson, AZ, ⁵Department of Rheumatology, University of Arizona, Tucson, AZ
Background/Purpose: In the Southwestern United States, coccidioidomycosis (valley fever) is an endemic fungal infection which typically causes a self-limited pulmonary illness. Immunosuppressed patients, including those…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].